NCT06100887Phase 2Active not recruiting

Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy

Study sponsor: Edgewise Therapeutics, Inc. · EWTX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-03Estimated

Enrollment · participants43Actual

Source updated2025-11-06Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2025-11-06 · 1 field changed

Primary completion date changed

− Before

~~Oct 2025~~

+ After

Mar 2027

Check registry source